Latest Zyvox Stories
-- Phase 1 Studies Confirm Superior Safety Profile of MRX-I Over Zyvox® -- HAYWARD, Calif. and SHANGHAI, Feb.
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
NEW YORK, Oct.
PHILADELPHIA, Sept. 2 /PRNewswire/ -- Pfizer, Inc.
Includes Allegations of Illicitly Promoting Antibiotic As Clinically Superior When Its Own FDA-Approved Label Said Otherwise; First-Ever Qui Tam Whistleblower Settlement of Its Type PHILADELPHIA, Sept. 2 /PRNewswire-USNewswire/ -- Pfizer Inc.
Paratek Pharmaceuticals, a developer of therapeutics for treating bacterial infections, has announced positive Phase II data of the company's lead antibiotic, PTK 0796, a first-in-class aminomethylcycline.
BOSTON, Oct. 26 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced positive Phase 2 data for the Company's lead antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC).
WATERTOWN, Mass., Sept.
Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received tentative approval from the FDA for its abbreviated new drug application for Linezolid tablets, 600mg. Linezolid tablets, an antibiotic, are the generic version of Pharmacia and Upjohn's Zyvox tablets.
WASHINGTON (Reuters) - U.S. regulators warned Pfizer Inc. about "misleading promotion" of its antibiotic drug Zyvox in a professional journal, according to a letter released on Tuesday.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.